Twist Bioscience Corp — Investor Relations & Filings

Twist Bioscience is a synthetic biology company that has developed a disruptive DNA synthesis platform. Leveraging a proprietary semiconductor-based manufacturing process, the company utilizes a high-throughput silicon platform to miniaturize and scale the production of synthetic DNA. Its product portfolio includes synthetic genes, oligo pools, variant libraries for drug discovery and protein engineering, and next-generation sequencing (NGS) tools such as target enrichment panels and synthetic controls. These offerings serve customers across diverse markets, including healthcare, agriculture, and industrial chemicals, enabling them to accelerate research and development in areas like drug discovery, cancer research, human genetics, and infectious disease.